Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

• Evan N. Cohen,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Hui Gao,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Simone Anfossi,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Michal Mego,

  Affiliation National Cancer Institute, Bratislava, Slovak Republic

  ⨯
• Neelima G. Reddy,

  Affiliation Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Bisrat Debeb,

  Affiliations Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Antonio Giordano,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Sanda Tin,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Qiong Wu,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Raul J. Garza,

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Massimo Cristofanilli,

  Affiliation Medical Oncology, Thomas Jefferson University, Philadelphia, PA, United States of America

  ⨯
• Sendurai A. Mani,

  Affiliations Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Denise A. Croix,

  Affiliation Roche Diagnostics, Indianapolis, IN, United States of America

  ⨯
• Naoto T. Ueno,

  Affiliations Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Wendy A. Woodward,

  Affiliations Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Raja Luthra,

  Affiliation Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Savitri Krishnamurthy,

  Affiliations Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
•  [ ... ],
• James M. Reuben

  * E-mail: jreuben@mdanderson.org

  Affiliations Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, The University of Texas Graduate School of Biomedical Sciences at Houston, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• [ view all ]
• [ view less ]